CMV Pp28 (UL99), CytomegaloVirus Antigen, Recombinant
| Full Name |
CMV Pp28 (UL99), CytomegaloVirus Antigen, Recombinant
|
Abbreviated Name-1 |
CMV Pp28 (UL99); |
| Documents |
| Figures |
| Reference |
|---|
Lazzarotto T, et al. The tegument protein ppUL25 of human cytomegalovirus (CMV) is a major target antigen for the anti-CMV antibody response. J. Gen. Virol. Feb 2001; 82(Pt 2): 335-338.
Wang Z, et al. Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood. Aug 2004; 104(3): 847-856.
Seo JY, Britt WJ. Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus. J. Virol. Jun 2006; 80(11): 5611-5626.
|
|
Description |
E. coli derived recombinant. CytomegaloVirus (CMV) Pp28 (UL99) contains the CMV Pp28 (UL99) immunodominant regions. The Pp28 protein is positioned within the tegument of the virus particle, a protein structure that resides between the capsid and envelope. In the infected cell, Pp28 is found in a cytoplasmic compartment derived from the Golgi apparatus, where the virus buds into vesicles to acquire its final membrane. CytomegaloVirus (CMV) Pp28 (UL99) is purified by proprietary chromatographic techniques.
|
Source |
E. coli |
Purity |
Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ml in 25 mM Tris-Hcl pH7.2, 1 mM EDTA, 50% glycerol. |
Stability |
Five years frozen. One month in solution at room temperature. |
Specificity |
Immunoreactive with sera of CMV-infected individuals. |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of CMV with minimal specificity problems. |
Note |
; |
Related Products
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|